160 related articles for article (PubMed ID: 22957435)
1. Modulation of drug release from nanocarriers loaded with a poorly water soluble drug (flurbiprofen) comprising natural waxes.
Baviskar DT; Amritkar AS; Chaudhari HS; Jain DK
Pharmazie; 2012 Aug; 67(8):701-5. PubMed ID: 22957435
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax.
Kheradmandnia S; Vasheghani-Farahani E; Nosrati M; Atyabi F
Nanomedicine; 2010 Dec; 6(6):753-9. PubMed ID: 20599527
[TBL] [Abstract][Full Text] [Related]
3. Novel dual-reverse thermosensitive solid lipid nanoparticle-loaded hydrogel for rectal administration of flurbiprofen with improved bioavailability and reduced initial burst effect.
Din FU; Mustapha O; Kim DW; Rashid R; Park JH; Choi JY; Ku SK; Yong CS; Kim JO; Choi HG
Eur J Pharm Biopharm; 2015 Aug; 94():64-72. PubMed ID: 25979136
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of flurbiprofen-loaded microemulsion for parenteral delivery.
Park KM; Kim CK
Int J Pharm; 1999 Apr; 181(2):173-9. PubMed ID: 10370213
[TBL] [Abstract][Full Text] [Related]
5. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC.
Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
Colloids Surf B Biointerfaces; 2010 Dec; 81(2):412-21. PubMed ID: 20719479
[TBL] [Abstract][Full Text] [Related]
6. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and
Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM
Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428
[No Abstract] [Full Text] [Related]
7. Development of flurbiprofen-loaded nanoparticles with a narrow size distribution using sucrose.
Oh DH; Yan YD; Kim DW; Kim JO; Yong CS; Choi HG
Drug Dev Ind Pharm; 2014 Feb; 40(2):172-7. PubMed ID: 23600652
[TBL] [Abstract][Full Text] [Related]
8. Preparation and Evaluation of N-Trimethyl Chitosan Nanoparticles of Flurbiprofen for Ocular Delivery.
Shinde UA; Joshi PN; Jain DD; Singh K
Curr Eye Res; 2019 May; 44(5):575-582. PubMed ID: 30632402
[TBL] [Abstract][Full Text] [Related]
9. Encapsulation and characterization of controlled release flurbiprofen loaded microspheres using beeswax as an encapsulating agent.
Ranjha NM; Khan H; Naseem S
J Mater Sci Mater Med; 2010 May; 21(5):1621-30. PubMed ID: 20217193
[TBL] [Abstract][Full Text] [Related]
10. Physicochemical characterization and in vivo evaluation of flurbiprofen-loaded solid dispersion without crystalline change.
Oh DH; Park YJ; Kang JH; Yong CS; Choi HG
Drug Deliv; 2011 Jan; 18(1):46-53. PubMed ID: 20726805
[TBL] [Abstract][Full Text] [Related]
11. Preparation and in vitro characterization of a semi-solid dispersion of flurbiprofen with Gelucire 44/14 and Labrasol.
Soliman MS; Khan MA
Pharmazie; 2005 Apr; 60(4):288-93. PubMed ID: 15881610
[TBL] [Abstract][Full Text] [Related]
12. Dermal flurbiprofen nanosuspensions: Optimization with design of experiment approach and in vitro evaluation.
Oktay AN; Karakucuk A; Ilbasmis-Tamer S; Celebi N
Eur J Pharm Sci; 2018 Sep; 122():254-263. PubMed ID: 29981401
[TBL] [Abstract][Full Text] [Related]
13. Design and optimization of NSAID loaded nanoparticles.
Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
[TBL] [Abstract][Full Text] [Related]
14. Development of colon specific microspheres of flurbiprofen for inflammatory bowel disease.
Sareen R; Jain N; Dhar KL
Curr Drug Deliv; 2013 Oct; 10(5):564-71. PubMed ID: 23360241
[TBL] [Abstract][Full Text] [Related]
15. Effect of binary solid lipid matrix of wax and triglyceride on lipid crystallinity, drug-lipid interaction and drug release of ibuprofen-loaded solid lipid nanoparticles (SLN) for dermal delivery.
Chantaburanan T; Teeranachaideekul V; Chantasart D; Jintapattanakit A; Junyaprasert VB
J Colloid Interface Sci; 2017 Oct; 504():247-256. PubMed ID: 28551519
[TBL] [Abstract][Full Text] [Related]
16. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery.
Kawadkar J; Pathak A; Kishore R; Chauhan MK
Drug Dev Ind Pharm; 2013 Apr; 39(4):569-78. PubMed ID: 22639934
[TBL] [Abstract][Full Text] [Related]
17. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
Song A; Zhang X; Li Y; Mao X; Han F
Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
[TBL] [Abstract][Full Text] [Related]
18. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML
Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662
[TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of colon specific drug delivery system containing flurbiprofen microsponges.
Orlu M; Cevher E; Araman A
Int J Pharm; 2006 Aug; 318(1-2):103-17. PubMed ID: 16687222
[TBL] [Abstract][Full Text] [Related]
20. Enhanced bioavailability of orally administered flurbiprofen by combined use of hydroxypropyl-cyclodextrin and poly(alkyl-cyanoacrylate) nanoparticles.
Zhao X; Li W; Luo Q; Zhang X
Eur J Drug Metab Pharmacokinet; 2014 Mar; 39(1):61-7. PubMed ID: 23700219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
